Latest News for: cns

Edit

AI Digital Currency Payments Breakthrough: LG CNS and Bank of Korea Unveil Revolutionary Agentic AI System

Bitcoin World 22 Jan 2026
In a landmark demonstration that could redefine the future of finance, LG CNS and the Bank of Korea have successfully tested a fully automated payment system for digital currencies powered by advanced agentic artificial intelligence.
Edit

LG CNS expands AI transformation push into pharma, biotech

Korea Times 21 Jan 2026
LG CNS, an IT services and digital transformation arm of LG Group, is ... In this project, LG CNS will lead in developing an AI-powered platform to design and support clinical trials for new drug research.
Edit

What To Expect From Cohen & Steers’s (CNS) Q4 Earnings

The Call 21 Jan 2026
Investment management firm Cohen & Steers (NYSE. CNS) will be announcing earnings results this Thursday afternoon. Here’s what investors should know ... Adjusted earnings are expected to come in at $0.81 per share ... P.S ... GO HERE NOW. More News. View More ... .
Edit

Cohen & Steers (CNS) Reports Q4: Everything You Need To Know Ahead Of Earnings

The Call 21 Jan 2026
Investment management firm Cohen & Steers (NYSE. CNS) will be announcing earnings results tomorrow after the bell. Here’s what you need to know ... Adjusted earnings are expected to come in at $0.81 per share ... P.S ... GO HERE NOW. More News. View More ... .
Edit

Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment

PR Newswire 21 Jan 2026
CAMBRIDGE, Mass., Jan ... Through the partnership, the two parties aim to accelerate the global advancement of ISM8969—an orally available, brain penetrant NLRP3 inhibitor for Central Nervous System (CNS) disorders ... Hygtia Therapeutics stated ... 21% ... .
Edit

LG CNS invests in CHA Biotech to fast-track AI-powered digital health care

Korea Times 15 Jan 2026
LG CNS is accelerating its digital health care business in partnership with CHA Biomedical Group, making a 10 billion won ($6.8 million) equity investment in its affiliate CHA Biotech.
Edit

[CES 2026] LG CNS CEO says industrial robots to enter production lines within 2 years

Korea Times 13 Jan 2026
LAS VEGAS — LG CNS CEO Hyun Shin-gyoon said industrial robots are expected to soon move beyond proof-of-concept (PoC) stages and begin working on production line ... He added that LG CNS is not pursuing ...
Edit

Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Image The Galveston Daily News 12 Jan 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Jan 12, 2026-- ....
Edit

LG CNS bags series of deals to modernize military IT networks

Korea Times 07 Jan 2026
LG CNS has secured two large-scale government projects aimed at modernizing Korea’s military information technology (IT) infrastructure, extending its reach into the country’s defense tech sector.
Edit

Initial Statement of Beneficial Ownership (Form 3) (CNS Pharmaceuticals Inc)

Public Technologies 02 Jan 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104 ... 0.5 ... 2 ... CNS Pharmaceuticals, Inc. [CNSP] ... C/O CNS PHARMACEUTICALS, INC., 100 WEST LOOP SOUTH, SUITE 900 4 ... C/O CNS PHARMACEUTICALS, INC ... CNS Pharmaceuticals Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (CNS Pharmaceuticals Inc)

Public Technologies 02 Jan 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... 0.5 ... 2 ... CNS Pharmaceuticals, Inc ... C/O CNS PHARMACEUTICALS, INC., 100 WEST LOOP SOUTH, SUITE 900 3 ... C/O CNS PHARMACEUTICALS, INC ... CNS Pharmaceuticals Inc.
Edit

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small ...

Business Wire 20 Dec 2025
T .
Edit

Support CN’s Middle East Coverage

Consortium News 20 Dec 2025
Shares. Seven-year old Consortium News in 2002 was one of the first outlets to reject the politicized intelligence for the disasters Iraq invasion and has run circles around corporate media on Syria and Gaza. But only with your help. April 18,1991 ... .
Edit

NeuraWorx Closes Oversubscribed Seed Round Led by Nexus NeuroTech to Advance Neurotechnology Therapy for CNS Disorders

Business Wire 19 Dec 2025
EXCELSIOR, Minn.--(BUSINESS WIRE)-- #CNSdisorders--NeuraWorx Closes Oversubscribed Seed Round Led by Nexus NeuroTech to Advance Neurotechnology Therapy for CNS Disorders ... .
Edit

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders - ResearchAndMarkets.com

Pharmiweb 19 Dec 2025
... (Neurodegenerative Disorders, Mental Health, Neurovascular Diseases, CNS Trauma, CNS Cancer, Other Disease Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).

Article Search

tools
×
×
×
×